We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+8.61%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.42B
AUM Growth
-$3.38B
Cap. Flow
-$3.75B
Cap. Flow %
-69.25%
Top 10 Hldgs %
40.63%
Holding
1,042
New
84
Increased
109
Reduced
414
Closed
284
Avg Time Held Equity + Options
3.7 quarters
Top 10 Avg Time Held Equity + Options
0.5 quarters
Top 20 Avg Time Held Equity + Options
0.8 quarters
Avg Time Held Equity only
3.7 quarters
Top 10 Avg Time Held Equity only
0.5 quarters
Top 20 Avg Time Held Equity only
0.8 quarters

Sector Composition

Rank Sector Weight
1 Financials 25.7%
2 Technology 18.31%
3 Healthcare 15.11%
4 Miscellaneous 11.75%
5 Real Estate 10.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SNRH
851
DELISTED
Senior Connect Acquisition Corp. I Class A Common Stock
SNRH
– –
-472,424
Closed -$4.7M –
MGI
852
DELISTED
MoneyGram International, Inc. New
MGI
– –
-6,917,249
Closed -$71.9M –
TCRR
853
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
– –
-54,035
Closed -$97K –
HZON
854
DELISTED
Horizon Acquisition Corporation II
HZON
– –
-464,113
Closed -$4.64M –
HZON.WS
855
DELISTED
Horizon Acquisition Corporation II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HZON.WS
– –
-233,880
Closed -$33K –
GWII
856
DELISTED
Good Works II Acquisition Corp. Common Stock
GWII
– –
-238,623
Closed -$2.39M –
CPARW
857
DELISTED
Catalyst Partners Acquisition Corp. Warrant
CPARW
$0 ﹤0.01%
188,060
– –
2022 Q1
3 quarters
ARCK
858
DELISTED
Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock
ARCK
– –
-381,797
Closed -$3.86M –
AEACW
859
DELISTED
Authentic Equity Acquisition Corp. Warrant
AEACW
$0 ﹤0.01%
53,853
– –
2021 Q1
7 quarters
DLCAW
860
DELISTED
Deep Lake Capital Acquisition Corp. Warrant
DLCAW
$0 ﹤0.01%
49,482
– –
2021 Q1
7 quarters
EPHYW
861
DELISTED
Epiphany Technology Acquisition Corp. Warrant
EPHYW
$0 ﹤0.01%
89,342
– –
2021 Q1
7 quarters
DRAYW icon
862
DELISTED
Macondray Capital Acquisition Corp. I Warrant
DRAYW
$0 ﹤0.01%
41,697
– –
2021 Q3
5 quarters
KAIR
863
DELISTED
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
– –
-379,815
Closed -$3.78M –
ASAX
864
DELISTED
Astrea Acquisition Corp. Class A Common Stock
ASAX
– –
-95,450
Closed -$939K –
GIIX
865
DELISTED
Gores Holdings VIII, Inc. Class A Common Stock
GIIX
– –
-702,344
Closed -$6.93M –
FACA
866
DELISTED
Figure Acquisition Corp. I
FACA
– –
-237,443
Closed -$2.34M –
CLAS
867
DELISTED
Class Acceleration Corp.
CLAS
– –
-123,643
Closed -$1.22M –
MDH
868
DELISTED
MDH Acquisition Corp.
MDH
– –
-698,192
Closed -$6.88M –
AKIC
869
DELISTED
Sports Ventures Acquisition Corp. Class A Ordinary Shares
AKIC
– –
-935,665
Closed -$9.32M –
AKICW
870
DELISTED
Sports Ventures Acquisition Corp. Warrant
AKICW
– –
-205,936
Closed -$14K –
ISAA
871
DELISTED
Iron Spark I Inc. Class A Common Stock
ISAA
– –
-413,612
Closed -$4.09M –
MNRL
872
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
– –
-131,400
Closed -$3.24M –
LFG
873
DELISTED
Archaea Energy Inc.
LFG
– –
-41,719
Closed -$751K –
FTVI
874
DELISTED
FinTech Acquisition Corp. VI Class A Common Stock
FTVI
– –
-467,890
Closed -$4.66M –
GACQ
875
DELISTED
Global Consumer Acquisition Corp. Common Stock
GACQ
– –
-369,227
Closed -$3.77M –

Similar funds

UBS O'Connor's Q4 2022 Portfolio in Review

As of Q4 2022, UBS O'Connor held 1,042 positions worth $5.42B, down 38% from $8.8B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor withdrew a net $3.75B in Q4 2022, closing 284 positions and reducing 414 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $572M position sold in full.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

Against the trend, UBS O'Connor opened a new position in Coupa Software Incorporated worth $128M.

  • UBS O'Connor's largest Q4 2022 buy was Coupa Software Incorporated: 1,619,333 shares worth $128M.
  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, an estimated $184M increase.
  • UBS O'Connor's biggest Q4 2022 reduction was Rogers Corp, cutting an estimated $219M.
  • UBS O'Connor fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $572M.
  • UBS O'Connor's ten largest holdings make up 41% of its $5.42B portfolio in Q4 2022.
  • UBS O'Connor opened 84 new positions and closed 284 in Q4 2022.
  • UBS O'Connor's portfolio value fell 38% quarter-over-quarter to $5.42B.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.